Critiquing the Politics, Policy & Practice of Development
patents
What kind of patent protection does India want?
The rejection of Bayer’s patent case in India is a landmark in defining the process by which patents are enforcable. It settles important questions on the limits of automatic patent protection provided by the system, providing a balance between private profit and public good.
Bargaining Through Compulsory Licensing: ARV Treatment in Brazil
The first study of its kind in Brazil on national drug spending illustrates how the threat of compulsory licensing can be an excellent bargaining tool to reducing patented drug costs.
WSJ to the WHO: In Defense of Patents
The Wall Street Journal defends patents, but disingenuously confuses the problems of high drug costs and poor delivery. Yet, the two issues are independent and require different approaches.
Categories
Most Emailed
- Financial Inclusion in India: Trends Beyond Microfinance - 34 emails
- A literature review of the impact of microfinance - 25 emails
- India’s Foreign Aid Program - 14 emails
- The Indo-US Nuclear Deal: A Post-Henry Hyde Act Analysis - 12 emails
- Nyama Choma at Olepolos - 9 emails
© 2007 The Discomfort Zone. 
